Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy

Cardiol J. 2022;29(2):362-363. doi: 10.5603/CJ.2022.0018.
No abstract available

MeSH terms

  • Acute Coronary Syndrome* / diagnosis
  • Acute Coronary Syndrome* / drug therapy
  • Acute Coronary Syndrome* / etiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Hyperlipoproteinemia Type II* / complications
  • Hyperlipoproteinemia Type II* / diagnosis
  • Hyperlipoproteinemia Type II* / drug therapy
  • Lipids
  • Plaque, Atherosclerotic* / drug therapy

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids